Skip to Content
  • Previous Rank
    -
  • Revenue 3 Yr Annual Growth Rate
    59%
  • Revenue 3 Yr Growth Rank
    5
  • EPS 3 Yr Annual Growth Rate
    161%
  • EPS 3 Yr Growth Rank
    5
  • Total Return 3 Yr Annual Rate
    11%
  • Total Return 3 Yr Rank
    87

Company Information

Revenue and net income for the four quarters ended on or before April 30, 2019. Total return for the period ended June 28, 2019.
Industry
Pharmaceuticals
Sector
Health Care
Current Streak-
Years on List1
CEO
Geoffrey Hulme
Websitehttps://www.inva.com
Country
U.S.
Headquarters
Brisbane, Calif.
Ticker
INVA

Revenue, Net Income

Revenue past four quarters ($M)$264
Net Income past four quarters ($M)$399
Market Value as of June 28, 2019 ($M)$1,474

Growth Rates and Ranks

Revenue 3 Yr Growth Rank5
Revenue 3 Yr Annual Growth Rate59%
EPS 3 Yr Growth Rank5
EPS 3 Yr Annual Growth Rate161%
Total Return 3 Yr Rank87
Total Return 3 Yr Annual Rate11%
Beat S&P 500 3 Yr Return (14.2%)
no